(Q36181299)

12 August 2017

title

Entacapone, a catechol-O-methyltransferase inhibitor for treating Parkinson's disease: review and current status (English)

1 reference

12 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

Gottwald MD

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

published in

1 reference

12 August 2017

volume

8

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

453-462

1 reference

The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.4.453

Concentration-effect relationship of levodopa in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.4.453

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.4.453

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.4.453

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.4.453

Entacapone in combination with standard or controlled-release levodopa/carbidopa: a clinical and pharmacokinetic study in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.4.453

The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.4.453

21 January 2018

Identifiers

DOI

10.1517/13543784.8.4.453

1 reference

12 August 2017

1 reference